Citadel Advisors - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0. A total of 22 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2021$42,800,000
-26.7%
45,128,000
-21.0%
0.01%
-28.6%
Q1 2021$58,386,000
+2.6%
57,128,000
-5.0%
0.01%
-6.7%
Q4 2020$56,891,000
+6.4%
60,128,0000.0%0.02%0.0%
Q3 2020$53,448,000
-25.9%
60,128,000
-18.9%
0.02%
-42.3%
Q2 2020$72,085,000
+13.9%
74,128,000
+16.0%
0.03%
-7.1%
Q1 2020$63,270,000
+0.6%
63,878,000
+6.6%
0.03%
+3.7%
Q4 2019$62,897,000
+23.4%
59,938,000
+9.1%
0.03%
+12.5%
Q3 2019$50,969,000
+9.8%
54,938,000
+2.8%
0.02%
+14.3%
Q2 2019$46,427,000
+62.0%
53,438,000
+81.5%
0.02%
+50.0%
Q1 2019$28,653,000
+1.6%
29,438,000
+7.3%
0.01%
-6.7%
Q4 2018$28,214,000
-8.1%
27,438,000
+5.9%
0.02%
+7.1%
Q3 2018$30,698,000
+20.1%
25,910,0000.0%0.01%
+7.7%
Q2 2018$25,565,000
+20.2%
25,910,000
+23.9%
0.01%
+8.3%
Q1 2018$21,264,000
-25.2%
20,910,000
-19.3%
0.01%
-29.4%
Q4 2017$28,415,000
-27.4%
25,910,000
-18.8%
0.02%
-43.3%
Q3 2017$39,150,000
+54.4%
31,910,000
+70.2%
0.03%
+42.9%
Q2 2017$25,363,000
+19.3%
18,750,000
+11.9%
0.02%
+10.5%
Q1 2017$21,257,000
+47.7%
16,750,000
+34.0%
0.02%
+26.7%
Q4 2016$14,393,00012,500,0000.02%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Context Capital Management, LLC 6,000,000$5,827,0003.55%
DeepCurrents Investment Group LLC 21,223,000$20,803,0001.80%
ZAZOVE ASSOCIATES LLC 19,230,000$18,725,0001.77%
Mohican Financial Management, LLC 500,000$494,0001.61%
Castle Creek Arbitrage, LLC 5,149,000$5,015,0001.47%
LINDEN ADVISORS LP 62,688,000$61,071,0001.40%
Verition Fund Management LLC 10,817,000$10,504,0000.41%
WOLVERINE ASSET MANAGEMENT LLC 24,100,000$23,451,0000.32%
Baupost Group 30,000,000$29,213,0000.24%
SSI INVESTMENT MANAGEMENT LLC 2,763,000$2,676,0000.22%
View complete list of THERAVANCE BIOPHARMA INC shareholders